Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
05/2010
05/11/2010US7713738 Oligomeric compounds for the modulation of survivin expression
05/11/2010US7713737 delivery construct, comprising a receptor binding domain, a transcytosis domain, a macromolecule to be delivered to a subject, and a cleavable linker
05/11/2010US7713736 Cell mimic platform and method
05/11/2010US7713724 Hydantoin racemase
05/11/2010US7713721 Methods and composition for the production of orthogonal tRNA-aminoacyltRNA synthetase pairs
05/11/2010US7713714 Isolated nona- and decapeptides which bind to HLA molecules, and the use thereof
05/11/2010US7713712 immunizing an animal with a mixture of different histidine fusion polypeptides and obtaining polyclonal antibodies directed against the histidine portion of the fusion polypeptides from the serum of the animal; rapid
05/11/2010US7713710 Isolation and use of solid tumor stem cells
05/11/2010US7713544 Biological component comprising artificial membrane
05/11/2010US7712252 Method of manufacturing a growth substrate
05/11/2010CA2392722C Male tissue-preferred regulatory region and method of using same
05/11/2010CA2366914C Enhanced system for construction of adenovirus vectors
05/11/2010CA2326401C Molecular regulatory circuits to achieve sustained activation of genes of interest by a single stress
05/11/2010CA2318887C Methods and compositions for modifying levels of secondary metabolic compounds in plants
05/11/2010CA2318492C Gene delivery vectors provided with a tissue tropism for smooth muscle cells, and/or endothelial cells
05/11/2010CA2274033C Biomaterial derived from vertebrate liver tissue
05/11/2010CA2254866C Methods for creating transgenic animals
05/11/2010CA2180965C Influenza vaccine
05/11/2010CA2140637C Genetic sequences encoding glycosyltransferase enzymes and uses therefor
05/11/2010CA2122365C Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines
05/08/2010CA2738644A1 Hepatitis c antibodies and uses thereof
05/06/2010WO2010051531A1 Olfactory epithelial-derived stem cells and methods of use therefor
05/06/2010WO2010051526A1 Methods for making induced pluripotent stem cells from mesenchymal stem cells
05/06/2010WO2010051329A2 Device for controlling the flow of anesthetic from a reservoir
05/06/2010WO2010051223A1 Differentiation of human embryonic stem cells to the pancreatic endocrine lineage
05/06/2010WO2010051213A1 Differentiation of human embryonic stem cells to the pancreatic endocrine lineage
05/06/2010WO2010051032A1 Method and device for activating stem cells
05/06/2010WO2010050802A2 Methods and means for efficient skipping of at least one of the following exons of the human duchenne muscular dystrophy gene: 43, 46, 50- 53.
05/06/2010WO2010050626A1 Method for producing induced pluripotent stem cells
05/06/2010WO2010050586A1 Method for enhancing expression of recombinant protein
05/06/2010WO2010050448A1 Peptide-containing culture medium for culturing animal cell
05/06/2010WO2010050231A1 Scyllo-inositol-producing cell and scyllo-inositol production method using said cells
05/06/2010WO2010050167A1 Composition for inducing th2 cell, therapeutic composition for th2-type disease, and use of same
05/06/2010WO2010049783A1 Stem cells in obstetrics and gynaecology
05/06/2010WO2010049752A1 Optimized methods for differentiation of cells into cells with hepatocyte and hepatocyte progenitor phenotypes, cells produced by the methods, and methods for using the cells
05/06/2010WO2010049563A1 Use of cyclodextrins for the production and extraction of phytosterols in cell cultures
05/06/2010WO2010049181A1 Storage of conjuctival cells
05/06/2010WO2010049152A1 Novel composition for the preparation of mature dendritic cells
05/06/2010WO2010048673A1 Modulation of cellular differentiation and uses therefor
05/06/2010WO2010029278A3 Isolation and identification of glycosaminoglycans
05/06/2010WO2010022714A3 Filter system for extracorporeal depletion of activated polymorphonuclear leukocytes (pmns)
05/06/2010WO2010016766A3 Antibodies recognizing endogenous human lgr5 and/or lgr6
05/06/2010WO2010014949A3 Compositions comprising hepatocyte-like cells and uses thereof
05/06/2010WO2010014622A3 In vitro model for modulating the blood brain barrier and methods of screening
05/06/2010WO2010011352A3 Compositions for mesoderm derived isl1+ multipotent cells (imps), epicardial progenitor cells (epcs) and multipotent cxcr4+cd56+ cells (c56cs) and methods of use
05/06/2010WO2009145945A3 Thermophilic and thermoacidophilic metabolism genes and enzymes from alicyclobacillus acidocaldarius and related organisms
05/06/2010WO2009132220A9 Isoprene synthase variants for improved microbial production of isoprene
05/06/2010US20100115670 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics in response to cold
05/06/2010US20100115669 Plant Cyclopropane Fatty Acid Synthase Genes, Proteins, And Uses Thereof
05/06/2010US20100115667 Novel At1g67330 gene involved in altered nitrate uptake efficiency
05/06/2010US20100115666 Transcriptional Repressors of Cytokinin Signaling and Their Use
05/06/2010US20100115665 Virus tolerant plants and methods of producing same
05/06/2010US20100115662 Manipulation of glutamine synthetases (gs) to improve nitrogen use efficiency and grain yield in higher plants
05/06/2010US20100115659 Differential expression of subgenome specific alleles in cotton and uses thereof
05/06/2010US20100115653 Cotton variety 07w902df
05/06/2010US20100115652 Cotton variety 07w903df
05/06/2010US20100115650 Herbicide-Resistant Brassica Plants and Methods of Use
05/06/2010US20100115649 Cotton variety 04x414df
05/06/2010US20100115648 Cotton variety 07w901df
05/06/2010US20100115647 Cotton variety 07w590df
05/06/2010US20100115646 Cotton variety 07w514df
05/06/2010US20100115645 Cotton variety 07w505df
05/06/2010US20100115644 Cotton variety 07x440df
05/06/2010US20100115643 Cotton variety 07v140df
05/06/2010US20100115642 Xenogenic immune system in a non-human mammal
05/06/2010US20100115641 Gfp-transfected clon pig, gt knock-out clon pig and methods for productions thereof
05/06/2010US20100115639 Antibodies inhibiting c-met dimerization and uses thereof
05/06/2010US20100113811 Delta-15 desaturases genes suitable for increasing levels of omega-3 fatty acids
05/06/2010US20100113753 Methods for preparing T-cells for cell therapy
05/06/2010US20100113745 Means and Methods for Influencing the Stability of Antibody Producing Cells
05/06/2010US20100113610 Methods for controlling inflammatory and immunological diseases
05/06/2010US20100113582 Methods and compositions for treating hiv infections
05/06/2010US20100113574 Polynucleotides for enhancing expression of a polynucleotide of interest
05/06/2010US20100113573 Modulation of hif1 beta expression
05/06/2010US20100113571 Compounds having anti-adhesive effects on cancer cells
05/06/2010US20100113569 Isolated dna fragment of the human a33 promoter and its use to control the expression of a heterologous gene in tumor cells
05/06/2010US20100113567 Recombinant VSV For The Treatment of Tumor Cells
05/06/2010US20100113566 Nucleic acid for treatment or prevention of immunodeficiency virus infection
05/06/2010US20100113560 Compositions and methods for treating hematopoietic malignancies
05/06/2010US20100113491 Synthesis of novel tubulin polymerization inhibitors: benzoylphenylurea (bpu) sulfur analogs
05/06/2010US20100113476 Chemical linkers with single amino acids and conjugates thereof
05/06/2010US20100113447 Triazole compounds that modulate hsp90 activity
05/06/2010US20100113441 Substituted imidazopyrimidines and triazolopyrimidines
05/06/2010US20100113373 Antiviral supplement formulations
05/06/2010US20100113369 Means for preventing and treating cellular death and their biological applications
05/06/2010US20100113361 Anti-ige vaccines
05/06/2010US20100113357 Platelet-derived growth factor-responsive neural precursor cells and progeny thereof
05/06/2010US20100113351 Therapeuting Compositions Comprising an RNAi Agent and a Neurotrophic Factor and Methods of Use Thereof
05/06/2010US20100113343 Methods involving lef-1 regulation and use of lef-1 or compounds altering lef-1 signalling for treating or preventing diseases
05/06/2010US20100113340 Nucleic acids coding for adhesion factor of group b streptococcus, adhesion factors of group b streptococcus and further uses thereof
05/06/2010US20100113339 Serum albumin binding proteins with long half-lives
05/06/2010US20100113335 Compositions and methods for treatement of cancer
05/06/2010US20100113328 Targeted delivery to legumain-expressing cells
05/06/2010US20100113327 Methods for controlling mineralization of extracellular matrix, therapeutic methods based thereon and medicaments for use therein
05/06/2010US20100113304 Compatible display vector systems
05/06/2010US20100113284 Small interfering rna (sirna) target site blocking oligos and uses thereof
05/06/2010US20100112700 Large scale disposable bioreactor
05/06/2010US20100112698 having a gas collection area in a tapered neck portion such that when used as a cell culturing apparatus, extraneous gas or bubbles are trapped and isolated from the cell growth areas where cells or media reside; efficiency
05/06/2010US20100112697 Process for the high-purity isolation of mesenchymal stem cells derived from placental chorionic plate membrane
05/06/2010US20100112694 Dedifferentiation of Adult Mammalian Cardiomyocytes into Cardiac Stem Cells